Thrivent Financial for Lutherans’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
PWAM
Thrivent Financial for Lutherans's FLGT Position: Q1 2025 in Review
Thrivent Financial for Lutherans sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 15,604 shares — an estimated $288K sold.
Thrivent Financial for Lutherans first reported a position in FLGT in Q3 2020 and held it in 18 quarters. The position peaked at $1.59M in Q4 2021. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.
- Thrivent Financial for Lutherans reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 15,604 Fulgent Genetics shares in Q1 2025, an estimated $288K.
- Thrivent Financial for Lutherans first reported a position in Fulgent Genetics in Q3 2020 and held it in 18 quarters.
- Thrivent Financial for Lutherans's Fulgent Genetics position peaked at $1.59M in Q4 2021.
- 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2025, filed 13 May 2025.